Insights into HIV-1 Reverse Transcriptase (RT) Inhibition and Drug Resistance from Thirty Years of Structural Studies

Insights into HIV-1 Reverse Transcriptase (RT) Inhibition and Drug Resistance from Thirty Years of Structural Studies

The enzyme reverse transcriptase (RT) plays a central role in the life cycle of human immunodeficiency virus (HIV), and RT has been an important drug target. Elucidations of the RT structures trapping and detailing the enzyme at various functional and conformational states by X-ray crystallography h...

Detaylı Bibliyografya
Asıl Yazarlar:	Abhimanyu K. Singh, Kalyan Das
Materyal Türü:	Makale
Dil:	English
Baskı/Yayın Bilgisi:	MDPI AG 2022-05-01
Seri Bilgileri:	Viruses
Konular:	HIV-RT NRTI NNRTI drug design structural biology crystallography
Online Erişim:	https://www.mdpi.com/1999-4915/14/5/1027

Benzer Materyaller

Approved HIV reverse transcriptase inhibitors in the past decade
Yazar:: Guangdi Li, ve diğerleri
Baskı/Yayın Bilgisi: (2022-04-01)

Mathematical Modelling of the Molecular Mechanisms of Interaction of Tenofovir with Emtricitabine against HIV
Yazar:: Sara Iannuzzi, ve diğerleri
Baskı/Yayın Bilgisi: (2021-07-01)

The “Connection” Between HIV Drug Resistance and RNase H
Yazar:: Krista A. Delviks-Frankenberry, ve diğerleri
Baskı/Yayın Bilgisi: (2010-07-01)

Associations between baseline characteristics, CD4 cell count response and virological failure on first-line efavirenz + tenofovir + emtricitabine for HIV
Yazar:: Oliver T. Stirrup, ve diğerleri
Baskı/Yayın Bilgisi: (2019-10-01)

Development of HIV Drug Resistance in a Cohort of Adults on First-Line Antiretroviral Therapy in Tanzania during the Stavudine Era
Yazar:: Raphael Z. Sangeda, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

Identification of a 3-aminoimidazo[1,2-a]pyridine inhibitor of HIV-1 reverse transcriptase
Yazar:: Elleder Daniel, ve diğerleri
Baskı/Yayın Bilgisi: (2012-12-01)

Efficacy and safety of novel russian non-nucleoside reverse transcriptase inhibitor elsulfavirine in combination with 2 nucleoside/nucleotide reverse transcriptase inhibitors in first-line HIV treatment – 96-week study
Yazar:: A. V. Kravchenko, ve diğerleri
Baskı/Yayın Bilgisi: (2018-07-01)

Diaryl ethers with carboxymethoxyphenacyl motif as potent HIV-1 reverse transcriptase inhibitors with improved solubility
Yazar:: Tomasz Frączek, ve diğerleri
Baskı/Yayın Bilgisi: (2018-01-01)

APOBEC3 selects V179I in HIV-1 reverse transcriptase to provide selective advantage for non-nucleoside reverse transcriptase inhibitor-resistant mutants
Yazar:: Richa Dwivedi, ve diğerleri
Baskı/Yayın Bilgisi: (2022-07-01)

Incidence and risk factors for neuropsychiatric events among Ghanaian HIV patients on long-term non-nucleoside reverse transcriptase inhibitor-based therapy
Yazar:: Fred S. Sarfo, ve diğerleri
Baskı/Yayın Bilgisi: (2016-06-01)

Biophysical Insights into the Inhibitory Mechanism of Non-Nucleoside HIV-1 Reverse Transcriptase Inhibitors
Yazar:: Nicolas Sluis-Cremer, ve diğerleri
Baskı/Yayın Bilgisi: (2013-11-01)

Chronic Hepatitis B Treatment Strategies Using Polymerase Inhibitor-Based Combination Therapy
Yazar:: Eriko Ohsaki, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01)

Picomolar inhibitor of reverse transcriptase featuring significantly improved metabolic stability
Yazar:: Ya-Li Sang, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

The long-term outcomes of antiretroviral treatment initiated with mono or dual nucleoside reverse transcriptase inhibitors in HIV-1-infected children: an Asian observational study
Yazar:: Orasri Wittawatmongkol, ve diğerleri
Baskı/Yayın Bilgisi: (2015-07-01)

Development of fluorine-substituted NH2-biphenyl-diarylpyrimidines as highly potent non-nucleoside reverse transcriptase inhibitors: Boosting the safety and metabolic stability
Yazar:: Xin Jin, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Thymidine Analogue Mutations with M184V Significantly Decrease Phenotypic Susceptibility of HIV-1 Subtype C Reverse Transcriptase to Islatravir
Yazar:: Hyeonah Byun, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Anti‐HIV drugs reduce risk of prediabetes and progression to type 2 diabetes in HIV‐infected patients
Yazar:: Joseph Magagnoli, ve diğerleri
Baskı/Yayın Bilgisi: (2023-06-01)

Scaffold Hopping in Discovery of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors: From CH(CN)-DABOs to CH(CN)-DAPYs
Yazar:: Ting-Ting Li, ve diğerleri
Baskı/Yayın Bilgisi: (2020-03-01)

Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Induced Neuropathy and Mitochondrial Toxicity: Limitations of the Poly-γ Hypothesis and the Potential Roles of Autophagy and Drug Transport
Yazar:: John Haynes, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

The Lysine 65 Residue in HIV-1 Reverse Transcriptase Function and in Nucleoside Analog Drug Resistance
Yazar:: Scott J. Garforth, ve diğerleri
Baskı/Yayın Bilgisi: (2014-10-01)

Structural Aspects of Drug Resistance and Inhibition of HIV-1 Reverse Transcriptase
Yazar:: Stefan G. Sarafianos, ve diğerleri
Baskı/Yayın Bilgisi: (2010-02-01)

Drug Resistance in Non-B Subtype HIV-1: Impact of HIV-1 Reverse Transcriptase Inhibitors
Yazar:: Kamalendra Singh, ve diğerleri
Baskı/Yayın Bilgisi: (2014-09-01)

Risk factors and outcomes for the Q151M and T69 insertion HIV-1 resistance mutations in historic UK data
Yazar:: Oliver T. Stirrup, ve diğerleri
Baskı/Yayın Bilgisi: (2018-04-01)

Evaluation of the HIV-1 drug resistance to elsulfavirine and the effectiveness of it among Russian treatment-naïve patients
Yazar:: A. A. Kirichenko, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Global Conformational Dynamics of HIV-1 Reverse Transcriptase Bound to Non-Nucleoside Inhibitors
Yazar:: Peter V. Coveney, ve diğerleri
Baskı/Yayın Bilgisi: (2012-07-01)

Drosophila model of anti-retroviral therapy induced peripheral neuropathy and nociceptive hypersensitivity
Yazar:: Keegan M. Bush, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Nucleoside Analog 2′,3′-Isopropylidene-5-Iodouridine as Novel Efficient Inhibitor of HIV-1
Yazar:: Ksenia Glumakova, ve diğerleri
Baskı/Yayın Bilgisi: (2023-09-01)

NNRTI-induced HIV-1 protease-mediated cytotoxicity induces rapid death of CD4 T cells during productive infection and latency reversal
Yazar:: Benjamin Trinité, ve diğerleri
Baskı/Yayın Bilgisi: (2019-06-01)

HIV drug resistance prediction with weighted categorical kernel functions
Yazar:: Elies Ramon, ve diğerleri
Baskı/Yayın Bilgisi: (2019-07-01)

HIV medication to prevent fetal infection during pregnancy
Yazar:: Teodora Gabriela Cioroba, ve diğerleri
Baskı/Yayın Bilgisi: (2022-03-01)

High frequency of Lamivudine and Telbivudine resistance mutations in hepatitis B virus isolates from human immunodeficiency virus co-infected patients on highly active antiretroviral therapy in Bucaramanga, Colombia
Yazar:: Henry Bautista-Amorocho, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Anthrarufin and Its Anionic Moieties as Potential Inhibitors of HIV-1 Reverse Transcriptase (RT)
Yazar:: Svetlana Jeremić, ve diğerleri
Baskı/Yayın Bilgisi: (2022-11-01)

K103N, V106M and Y188L Significantly Reduce HIV-1 Subtype C Phenotypic Susceptibility to Doravirine
Yazar:: Nikita Reddy, ve diğerleri
Baskı/Yayın Bilgisi: (2024-09-01)

Virulence and Replicative Fitness of HIV-1 Transmitted/Founder (T/F) Viruses Harbouring Drug Resistance-Associated Mutation
Yazar:: Aanand Sonawane, ve diğerleri
Baskı/Yayın Bilgisi: (2024-11-01)

Machine learning aided multiscale modelling of the HIV-1 infection in the presence of NRTI therapy
Yazar:: Huseyin Tunc, ve diğerleri
Baskı/Yayın Bilgisi: (2023-03-01)

Targeting the Structural Maturation Pathway of HIV-1 Reverse Transcriptase
Yazar:: Thomas W. Kirby, ve diğerleri
Baskı/Yayın Bilgisi: (2023-11-01)

The Molecular Docking of Specific Reverse Transcriptase Inhibitory Ligands onto the Molecular Model of HIV-1 Reverse Transcriptase
Yazar:: Roohallah Yousefi
Baskı/Yayın Bilgisi: (2024-06-01)

Virtual screening, molecular docking studies and DFT calculations of FDA approved compounds similar to the non-nucleoside reverse transcriptase inhibitor (NNRTI) efavirenz
Yazar:: Maryam A. Jordaan, ve diğerleri
Baskı/Yayın Bilgisi: (2020-08-01)

Structure-Based Discovery and Characterization of a Preclinical Drug Candidate for the Treatment of HIV-1 Infection
Yazar:: Dongwei Kang, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01)

Transmitted drug resistance to rilpivirine among antiretroviral‐naïve patients living with HIV from northern Poland
Yazar:: Miłosz Parczewski, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)